Lanzone, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 14.299
EU - Europa 11.518
AS - Asia 10.656
SA - Sud America 1.982
AF - Africa 303
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 9
Totale 38.804
Nazione #
US - Stati Uniti d'America 13.886
SG - Singapore 5.017
DE - Germania 3.095
CN - Cina 2.130
BR - Brasile 1.588
SE - Svezia 1.493
PL - Polonia 1.422
IT - Italia 1.418
VN - Vietnam 1.185
FR - Francia 968
UA - Ucraina 661
GB - Regno Unito 609
IE - Irlanda 422
NL - Olanda 422
IN - India 384
FI - Finlandia 318
BD - Bangladesh 304
ID - Indonesia 301
JP - Giappone 287
HK - Hong Kong 243
RU - Federazione Russa 210
CA - Canada 201
TR - Turchia 170
AR - Argentina 155
MX - Messico 112
IQ - Iraq 102
BE - Belgio 93
AT - Austria 71
ZA - Sudafrica 70
PK - Pakistan 67
EC - Ecuador 62
ES - Italia 57
IR - Iran 55
CI - Costa d'Avorio 52
KR - Corea 51
CO - Colombia 45
VE - Venezuela 43
PH - Filippine 42
CZ - Repubblica Ceca 40
MA - Marocco 40
UZ - Uzbekistan 36
CH - Svizzera 35
SA - Arabia Saudita 33
LT - Lituania 32
AE - Emirati Arabi Uniti 31
JO - Giordania 31
EG - Egitto 29
KE - Kenya 27
AU - Australia 25
CL - Cile 25
RO - Romania 22
AZ - Azerbaigian 21
IL - Israele 21
NP - Nepal 19
PE - Perù 19
MY - Malesia 18
JM - Giamaica 17
PT - Portogallo 17
PY - Paraguay 17
ET - Etiopia 16
DO - Repubblica Dominicana 15
UY - Uruguay 15
DZ - Algeria 14
LV - Lettonia 14
NO - Norvegia 14
CR - Costa Rica 13
BG - Bulgaria 12
TN - Tunisia 12
KZ - Kazakistan 11
NZ - Nuova Zelanda 11
PA - Panama 11
TH - Thailandia 11
HU - Ungheria 10
AL - Albania 9
BO - Bolivia 9
PS - Palestinian Territory 9
BB - Barbados 8
GR - Grecia 7
HN - Honduras 7
HR - Croazia 7
KG - Kirghizistan 7
LK - Sri Lanka 7
MD - Moldavia 7
RS - Serbia 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
AO - Angola 6
GE - Georgia 6
LB - Libano 6
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
BY - Bielorussia 5
GA - Gabon 5
KH - Cambogia 5
KW - Kuwait 5
LA - Repubblica Popolare Democratica del Laos 5
LU - Lussemburgo 5
SN - Senegal 5
CG - Congo 4
Totale 38.718
Città #
Singapore 2.922
Chandler 1.941
Ashburn 1.425
San Jose 1.410
Warsaw 1.363
Beijing 463
Dallas 455
New York 446
Dublin 416
Jacksonville 386
Ho Chi Minh City 385
Amsterdam 369
Los Angeles 366
San Mateo 362
Hanoi 293
Fairfield 283
Jakarta 262
Tokyo 259
Lauterbourg 258
Rome 256
Wilmington 255
Milan 242
Munich 228
The Dalles 216
Hefei 210
Boston 202
Hong Kong 201
Frankfurt am Main 200
Houston 198
Ann Arbor 194
Woodbridge 183
Nanjing 178
Seattle 176
Marseille 174
Nürnberg 174
Dearborn 168
Princeton 143
São Paulo 136
Helsinki 120
Lancaster 119
Cambridge 115
Cattolica 114
Bremen 113
Council Bluffs 109
Chicago 108
Moscow 107
Santa Clara 103
Buffalo 90
Brussels 87
Izmir 87
Redwood City 80
Lawrence 77
London 74
Da Nang 70
Nanchang 68
Atlanta 63
Düsseldorf 60
Montreal 60
Paris 60
Mountain View 59
Rio de Janeiro 58
Boardman 57
Denver 56
Nuremberg 56
Orem 56
University Park 56
Chennai 54
Shanghai 54
Brooklyn 53
Toronto 53
Augusta 52
Kent 52
Abidjan 50
Shenyang 50
Zhengzhou 47
Leawood 46
Johannesburg 45
Mexico City 45
Seoul 45
Hebei 44
Phoenix 43
Turku 43
Vienna 43
San Francisco 41
Baghdad 40
Haiphong 40
Norwalk 39
Pune 39
Tianjin 39
Belo Horizonte 37
Fremont 37
Redmond 37
Guangzhou 33
Dhaka 32
Hangzhou 32
Stockholm 32
St Louis 30
Poplar 29
Tashkent 29
Lappeenranta 28
Totale 21.493
Nome #
Effect of human chorionic gonadotropin administration on pituitary and luteal response to gonadotropin-releasing hormone 413
A Network Analysis of Perinatal Depression, Anxiety, and Temperaments in Women in the First, Second, and Third Trimesters of Pregnancy 388
In vitro human growth hormone increases human chorionic gonadotropin and progesterone secretion by human placenta at term: evidence of a modulatory role by opioids 336
Indomethacin in vivo inhibits the enhancement of the progesterone secretion in response to gonadotrophin-releasing hormone by human corpus luteum 326
Effect of activin-A on progesterone synthesis in human luteal cells 320
Effect of activin-A on progesterone synthesis in human luteal cells 318
Human growth hormone enhances progesterone production by human luteal cells in vitro. II. Evidence of a distinct effect on two luteal cell types 308
Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action 306
Insulin secretion in patients with gestational diabetes: relationship with pregnancy outcome 300
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium 295
Insulin plasma levels in pregnant patients with impaired glucose tolerance: relationship with pregnancy outcome 291
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 290
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. 281
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease 278
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 278
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 243
Excretion of SARS-CoV-2 in human breast milk 237
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 222
Circulating irisin levels in functional hypothalamic amenorrhea: a new bone damage index? A pilot study. 218
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 212
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 211
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 208
17β-estradiol protects cerebellar granule cells against β-amyloid-induced toxicity via the apoptotic mitochondrial pathway 203
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 200
Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center 199
The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status 197
The "Preeclampsia and Hypertension Target Treatment" ("PYTT") study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 192
Recurrent miscarriage and fetal congenital malformations: Is there a neglected causal association? 192
L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism 188
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 188
L'applicazione del Nuovo Ordinamento del CLM in Medicina e Chirurgia. Le ragioni di un percorso e di una proposta innovativa di Piano di studi nella Facoltà di Medicina e Chirurgia dell'Università Cattolica di Roma 183
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 182
Adult onset Still's disease and pregnancy 182
Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics 181
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 180
Look at the lung: can chest ultrasonography be useful in pregnancy? 179
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis 178
Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women. 177
Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic 176
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 176
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 175
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples 174
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 174
Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings 173
Persistence of right umbilical vein: A singular case 172
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact 171
Is there any role for the Hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment? 171
Is gestational hypertension beneficial in twin pregnancies? 171
The transition from intra to extra-uterine life in late preterm infant: a single-center study 171
Autoimmunity in obstetrics and autoimmune diseases in pregnancy 171
Ovarian Volume And Gluco-Insulinaemic Markers In The Diagnosis Of Pcos During Adolescence 170
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 170
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 169
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 169
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 168
Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women 167
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 167
Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study 166
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 165
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 164
Carbohydrate metabolism in gestational diabetes: effect of chronic hypertension 163
Prenatal valacyclovir treatment of fetal citomegalovirus infection: A case series 163
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 161
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study. 161
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis. 160
Look at the lung: can chest ultrasonography be useful in pregnancy? 160
The use of different size-hysteroscope in office hysteroscopy: our experience 159
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 159
How Metformin Acts in PCOS Pregnant Women: Insights in insulin secretion and peripheral action at each trimester of gestation. 157
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 157
Look at the lung: can chest ultrasonography be useful in pregnancy? 157
The transition from intra to extra-uterine life in late preterm infant: a single-center study 155
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 154
Metformin versus myoinositol: which is better in obese PCOS patients? A randomized controlled crossover study 154
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 154
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 152
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study. 152
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 152
A multi-approach management intervention can lower C-section rate trends: The experience of a Third Level Referral Center de Belvis A.G., Neri C., Angioletti C., Carducci B., Ferrazzani S., Lanzone A., Caruso A. 151
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: Towards specific guidelines and standard operating procedures for the molecular diagnosis 150
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 150
Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. 150
Epidermal growth factor levels in human breast cyst fluid 150
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 150
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study 150
Relationships Between Thyroid Hormones, Insulin-Like Growth Factor-1 and Antioxidant Levels in Hypothalamic Amenorrhea and Impact on Bone Metabolism 150
Role of Human Leukocyte Antigens at the Feto-Maternal Interface in Normal and Pathological Pregnancy: An Update. 150
SARS-CoV-2 Infection in Pregnancy: Clinical Signs, Placental Pathology, and Neonatal Outcome—Implications for Clinical Care 150
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 149
Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women 148
Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up 147
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 147
Assessing Doubts, Knowledge, and Service Appreciation among Pregnant Women Who Received the COVID-19 Vaccination in an Italian Research Hospital: A Cross-Sectional Study 146
Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity? 146
Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? 146
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 144
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 143
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 143
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 143
Fetal Central Nervous System and Infectious Diseases 143
Totale 19.106
Categoria #
all - tutte 149.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/20222.086 161 138 32 165 79 83 49 382 78 117 340 462
2022/20235.067 644 681 373 811 279 661 280 408 587 92 185 66
2023/20242.463 115 626 70 122 97 437 209 89 43 108 214 333
2024/20255.324 112 146 366 181 520 151 174 265 718 496 1.216 979
2025/202615.556 2.023 466 1.132 1.667 2.737 1.079 2.678 691 1.066 1.010 650 357
Totale 39.280